Bath & Body Works' (BBWI) Hold (C-) Rating Reiterated at Weiss Ratings

Key Points

• Bath & Body Works (BBWI) has had its "hold (C-)" rating reaffirmed by Weiss Ratings, while several other analysts have also set neutral or lower ratings, indicating uncertainty in the stock's performance.
• JPMorgan Chase maintains a price target of $26.00, while UBS Group reduced its target to $32.00, reflecting a cautious outlook amid recent stock volatility.
• The company's recent earnings report showed revenue of $1.55 billion and earnings per share of $0.37, meeting analyst expectations but indicating a 0.8% decline year-over-year.

Bath & Body Works (NYSE:BBWI - Get Free Report)'s stock had its "hold (c-)" rating reiterated by investment analysts at Weiss Ratings in a report released on Friday,Weiss Ratings reports.

Several other equities research analysts have also weighed in on BBWI. UBS Group cut their target price on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating on the stock in a report on Friday, August 29th. JPMorgan Chase & Co. restated a "neutral" rating and set a $26.00 price objective on shares of Bath & Body Works in a report on Monday, October 6th. Wall Street Zen lowered shares of Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Citigroup dropped their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a report on Tuesday, August 19th. Finally, Morgan Stanley dropped their price objective on shares of Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating on the stock in a report on Friday, September 12th. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $37.18.

Bath & Body Works Price Performance

BBWI traded down $0.07 during mid-day trading on Friday, hitting $26.99. The stock had a trading volume of 4,163,162 shares, compared to its average volume of 5,510,945. The stock's fifty day simple moving average is $27.54 and its 200-day simple moving average is $29.05. The firm has a market capitalization of $5.56 billion, a price-to-earnings ratio of 8.01, a price-to-earnings-growth ratio of 0.90 and a beta of 1.52. Bath & Body Works has a 1-year low of $24.85 and a 1-year high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting the consensus estimate of $0.37. The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business's revenue for the quarter was down .8% compared to the same quarter last year. During the same period last year, the business posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. T. Rowe Price Investment Management Inc. grew its position in shares of Bath & Body Works by 7.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock valued at $334,029,000 after acquiring an additional 781,681 shares during the period. JPMorgan Chase & Co. grew its position in shares of Bath & Body Works by 11.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company's stock valued at $212,120,000 after acquiring an additional 733,000 shares during the period. Victory Capital Management Inc. grew its position in shares of Bath & Body Works by 14,732.0% in the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock valued at $206,119,000 after acquiring an additional 6,752,274 shares during the period. Alliancebernstein L.P. grew its position in shares of Bath & Body Works by 5.8% in the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company's stock valued at $171,904,000 after acquiring an additional 315,738 shares during the period. Finally, Cooper Creek Partners Management LLC grew its position in shares of Bath & Body Works by 42.7% in the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company's stock valued at $162,081,000 after acquiring an additional 1,619,276 shares during the period. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.